The Beneficial Role of Lactobacillus paracasei subsp. paracasei NTU 101 in the Prevention of Atopic Dermatitis

Chin-Feng Liu,Tsung-Wei Shih,Chun-Lin Lee,Tzu-Ming Pan

DOI: https://doi.org/10.3390/cimb46030143

2024-03-09

Current Issues in Molecular Biology

Abstract:Atopic dermatitis (AD) is a recurrent allergic disease characterized by symptoms such as itching, redness, swelling, dryness, scaling skin, inflammation, and tissue damage. The underlying pathogenesis of AD remains unclear. Steroid drugs are commonly used in the clinical treatment of AD; however, their long-term use may lead to associated complications. Numerous studies have indicated that probiotics could modulate the immune system, enhance immune function, or suppress excessive immune responses. In this study, Lactobacillus paracasei subsp. paracasei NTU 101 (NTU 101) was orally administered for a duration of 4 weeks, followed by the induction of AD using ovalbumin (OVA) in a mouse model. The skin condition of the stimulated site was observed during the induction period. Subsequently, the serum immunoglobulin E (IgE) content, splenocyte T cell typing, and skin histological interpretation were examined to evaluate the efficacy of NTU 101 in alleviating AD symptoms in allergen-exposed animals. The findings indicated that administering NTU 101 beforehand effectively alleviated skin symptoms in animals with AD. It reduced the infiltration of inflammatory cells in skin tissue sections, and compared to the OVA group, there was a significant reduction in the thickening of the epidermal cell layer (decreased from 89.0 ± 20.2 μM to 48.6 ± 16.0 μM) and dermis layer (decreased from 310.3 ± 69.0 μM to 209.7 ± 55.5 μM). Moreover, the proportion of regulatory T (Treg) cells and T helper 2 (Th2) cells in splenocytes significantly increased, while the proportions of T helper 1 (Th1) and T helper 17 (Th17) cells did not differ. It is speculated that the potential mechanism by which NTU 101 prevents AD involves increasing the expression of Forkhead box protein P3 (FOXP3) and promoting Treg cell maturation, thereby alleviating allergic reaction symptoms associated with AD.

biochemistry & molecular biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to evaluate the role of Lactobacillus paracasei subsp. NTU 101 in preventing and alleviating atopic dermatitis (AD). Specifically, the study observed the effect of NTU 101 on AD symptoms by orally administering NTU 101 to a mouse model for 4 weeks and then inducing AD using ovalbumin (OVA). The main purpose of the study was to explore whether NTU 101 could effectively reduce the symptoms of AD and to explore its potential mechanism of action.

### Research Background
Atopic dermatitis (AD) is a chronic inflammatory skin disease, mainly manifested as symptoms such as itching, erythema, swelling, dryness, desquamation, inflammation and tissue damage. Although the pathogenesis of AD is not fully understood, it is known to be related to the complex interaction of genetic and environmental factors. Currently, the commonly used method for treating AD in clinical practice is the use of corticosteroid drugs, but long - term use may lead to side effects. In recent years, studies have shown that probiotics may improve AD symptoms by regulating the immune system, enhancing immune function or suppressing excessive immune responses.

### Research Methods
1. **Experimental Animals and Grouping**
- Five - week - old BALB/c mice were used in the experiment and randomly divided into 5 groups:
- Control group (NOR group): Only received normal saline treatment and a normal diet.
- OVA group: Induced systemic sensitivity and local skin irritation through OVA, and had a normal diet.
- Clinical Medication group (CM group): Pretreated with prednisone for 28 days, then induced with OVA, and had a normal diet.
- NTU 101 group: Pretreated with NTU 101 (1×10^11 CFU/day) for 28 days, then induced with OVA, and had a normal diet.
- LGG group: Pretreated with L. rhamnosus GG ATCC 53103 (1×10^11 CFU/day) for 28 days, then induced with OVA, and had a normal diet.

2. **Experimental Design**
- Mice were orally administered the corresponding treatment substances once a day for 4 weeks.
- Starting from the 5th week, systemic sensitivity was induced by intraperitoneal injection of OVA, and then skin irritation was carried out by local application of OVA, with a cycle of every 7 days for a total of 3 cycles.

3. **Observation Indicators**
- **Skin Condition Score**: The skin condition was recorded every 3 - 4 days, and the scoring criteria were as follows:
- Asymptomatic: 0 points
- Scratch: 1 point
- Erythema: 2 points
- Skin rupture/desquamation: 3 points
- Mucus/body fluid production: 4 points
- Mucus/body fluid production/pus/blood: 5 points
- **Blood Analysis**: Blood samples were collected to detect the total IgE level and the OVA - specific IgE level.
- **Cell Population Analysis**: The proportions of CD4+ T cells, Th1 cells, Th2 cells, Th17 cells and Treg cells in splenocytes were detected by flow cytometry.
- **Histopathological Analysis**: Skin tissues at the stimulation site were taken for HE staining and immunohistochemical analysis to evaluate the infiltration of inflammatory cells and the changes in the thickness of the epidermis and dermis.

### Research Results
1. **Changes in Body Weight and Food Intake**
- At the beginning of the experiment, the body weights of mice in each group were similar. In the early stage of the experiment (days 0 - 28), the body weights of mice increased steadily, but the body weight of the CM group was significantly lower than that of the OVA group (p < 0.05; p < 0.01). During the skin irritation period (days 42, 56, 70), the average body weights of mice in each group decreased, presumably because the mice needed to be bandaged during the skin irritation period, which affected food intake and skin irritation. However, after the bandages were removed, the body weights of the mice gradually recovered.

2. **Skin Condition Score**
- During the first skin irritation period (day 40), the average score of the OVA group was significantly higher than that of the NOR group (p < 0.05). Although the scores of the NTU 101 group and the LGG group were lower than those of the OVA group, the differences were not significant. During the non - irritation period (days 47, 50), the skin recovery speed of the OVA group was slow, and the score was significantly higher than that of the NOR group (p < 0.001), while the score of the NTU 101 group was significantly lower than that of the OVA group (p < 0.001), close to that of the NOR group.

3. **Histopathology**